MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune booster aims to stop Cancer's return in advanced nasopharyngeal cancer
Disease control Not yet recruitingThis study tests whether adding Natural Killer (NK) cells from healthy donors to standard chemoradiotherapy can lower the chance of cancer returning in people with advanced nasopharyngeal cancer. About 31 participants will receive different doses of NK cells to find the safest an…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Could chemo before surgery beat standard care for colon cancer?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus surgery alone for people with stage II or III colon cancer that has a high chance of coming back. About 100 adults aged 18-70 will be randomly assigned to one of two groups. The goal is to see if pre-surgery chemo impr…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Blood test may predict liver cancer return and guide treatment
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tiny bits of tumor DNA (called minimal residual disease) can predict if liver cancer will come back after surgery. Researchers will follow 276 patients who had their liver cancer removed and test their blood over time. The goa…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC